rs2942

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001278064.2(GRM1):​c.2793G>A​(p.Lys931Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.518 in 1,613,152 control chromosomes in the GnomAD database, including 218,066 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.50 ( 19385 hom., cov: 32)
Exomes 𝑓: 0.52 ( 198681 hom. )

Consequence

GRM1
NM_001278064.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.44

Publications

35 publications found
Variant links:
Genes affected
GRM1 (HGNC:4593): (glutamate metabotropic receptor 1) This gene encodes a metabotropic glutamate receptor that functions by activating phospholipase C. L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The canonical alpha isoform of the encoded protein is a disulfide-linked homodimer whose activity is mediated by a G-protein-coupled phosphatidylinositol-calcium second messenger system. This gene may be associated with many disease states, including schizophrenia, bipolar disorder, depression, and breast cancer. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2013]
GRM1 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia 44
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal recessive spinocerebellar ataxia 13
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 6-146434004-G-A is Benign according to our data. Variant chr6-146434004-G-A is described in ClinVar as Benign. ClinVar VariationId is 129209.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.44 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.583 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRM1NM_001278064.2 linkc.2793G>A p.Lys931Lys synonymous_variant Exon 8 of 8 ENST00000282753.6 NP_001264993.1 Q13255-1Q59HC2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRM1ENST00000282753.6 linkc.2793G>A p.Lys931Lys synonymous_variant Exon 8 of 8 1 NM_001278064.2 ENSP00000282753.1 Q13255-1

Frequencies

GnomAD3 genomes
AF:
0.504
AC:
76545
AN:
151844
Hom.:
19359
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.485
Gnomad AMI
AF:
0.472
Gnomad AMR
AF:
0.469
Gnomad ASJ
AF:
0.563
Gnomad EAS
AF:
0.515
Gnomad SAS
AF:
0.600
Gnomad FIN
AF:
0.449
Gnomad MID
AF:
0.490
Gnomad NFE
AF:
0.522
Gnomad OTH
AF:
0.512
GnomAD2 exomes
AF:
0.504
AC:
126597
AN:
251376
AF XY:
0.512
show subpopulations
Gnomad AFR exome
AF:
0.491
Gnomad AMR exome
AF:
0.385
Gnomad ASJ exome
AF:
0.572
Gnomad EAS exome
AF:
0.509
Gnomad FIN exome
AF:
0.448
Gnomad NFE exome
AF:
0.518
Gnomad OTH exome
AF:
0.519
GnomAD4 exome
AF:
0.519
AC:
758842
AN:
1461188
Hom.:
198681
Cov.:
46
AF XY:
0.523
AC XY:
380004
AN XY:
726938
show subpopulations
African (AFR)
AF:
0.487
AC:
16315
AN:
33470
American (AMR)
AF:
0.392
AC:
17532
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.566
AC:
14797
AN:
26122
East Asian (EAS)
AF:
0.494
AC:
19607
AN:
39698
South Asian (SAS)
AF:
0.599
AC:
51684
AN:
86240
European-Finnish (FIN)
AF:
0.449
AC:
23972
AN:
53372
Middle Eastern (MID)
AF:
0.559
AC:
3227
AN:
5768
European-Non Finnish (NFE)
AF:
0.522
AC:
579826
AN:
1111424
Other (OTH)
AF:
0.528
AC:
31882
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
23304
46609
69913
93218
116522
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16636
33272
49908
66544
83180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.504
AC:
76608
AN:
151964
Hom.:
19385
Cov.:
32
AF XY:
0.502
AC XY:
37242
AN XY:
74242
show subpopulations
African (AFR)
AF:
0.485
AC:
20120
AN:
41466
American (AMR)
AF:
0.469
AC:
7160
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.563
AC:
1954
AN:
3468
East Asian (EAS)
AF:
0.516
AC:
2650
AN:
5132
South Asian (SAS)
AF:
0.601
AC:
2894
AN:
4812
European-Finnish (FIN)
AF:
0.449
AC:
4736
AN:
10554
Middle Eastern (MID)
AF:
0.476
AC:
140
AN:
294
European-Non Finnish (NFE)
AF:
0.522
AC:
35436
AN:
67940
Other (OTH)
AF:
0.516
AC:
1089
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1946
3892
5838
7784
9730
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
696
1392
2088
2784
3480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.521
Hom.:
74791
Bravo
AF:
0.500
Asia WGS
AF:
0.566
AC:
1971
AN:
3478
EpiCase
AF:
0.534
EpiControl
AF:
0.535

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jul 15, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 25, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Autosomal recessive spinocerebellar ataxia 13 Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spinocerebellar ataxia 44 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
6.3
DANN
Benign
0.60
PhyloP100
1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2942; hg19: chr6-146755140; COSMIC: COSV51124862; API